Recent research is focused on gene therapy and advanced enzyme replacement therapies to treat GSDs more effectively. Studies are also exploring the potential of CRISPR-Cas9 technology to correct the underlying genetic mutations that cause these diseases. Additionally, new imaging techniques in histology are improving the ability to diagnose and monitor glycogen storage diseases more accurately.
